查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620750

精准医疗市场：依技术、应用程式、最终用户、配置- 2025-2030 年全球预测

Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年精准医疗市场估值为681.2亿美元，预计2024年将达757亿美元，复合年增长率为11.22%，预计2030年将达1434.3亿美元。

精准医学考虑遗传、环境方面和生活方式等因素，根据每位患者的个别特征制定治疗方案。这种方法透过实现更个人化和有效的医疗保健解决方案正在重塑医疗实践。癌症、心血管疾病和遗传性疾病等疾病管理中对个人化治疗计划的需求不断增长，推动了对精准医疗的需求，这些计划有可能改善患者的治疗效果并降低医疗成本。精准医学的应用范围涵盖基因组学、数位健康技术和生物标记分析，对于药物开发、早期疾病检测和治疗方法选择至关重要。最终用途范围广泛，影响生物製药、诊断公司和医疗保健提供者等行业。成长要素包括基因组学的进步、研发投资的增加以及对标靶治疗的日益重视。此外，政府的支持以及生物技术公司和学术机构之间的合作正在支持市场扩张。新的商机在于人工智慧驱动的基因组分析和巨量资料的整合以增强预测结果。对于希望抓住这些机会的公司来说，投资资料分析并建立创新解决方案的伙伴关係关係至关重要。然而，存在一些可能抑製成长的挑战，例如高开发成本、资料隐私问题和监管障碍。医疗保健提供者和患者的认识和接受度有限也是一个主要障碍。创新的最佳领域包括开发具有成本效益的基因组技术和精确诊断的进步。透过探索促进患者可及性和参与度的新经营模式，预计将进一步成长。市场本质上是动态的，快速的技术进步需要相关人员的敏捷性和远见。公司应专注于整合最尖端科技并创建可扩展的解决方案，以保持竞争力，同时满足个人化医疗保健的细微差别需求。

主要市场统计
基准年[2023] 681.2亿美元
预计年份 [2024] 757亿美元
预测年份 [2030] 1434.3亿美元
复合年增长率（%） 11.22%

市场动态：揭示快速发展的精准医疗市场的关键市场洞察

供需的动态交互作用正在改变精准医疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 更多政府资助和更多线上协作论坛
    • 人工智慧在精准医疗的应用不断增加
    • 新兴企业积极进入，癌症生物学取得进展
  • 市场限制因素
    • 精准医疗治疗缺乏报销
  • 市场机会
    • 精准医疗中越来越多地采用云端基础的解决方案
    • 製药公司与软体公司建立策略伙伴关係来表征基因
  • 市场挑战
    • FDA 复杂药物治疗核准率

波特五力：驾驭精准医疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解精准医疗市场的外部影响

外部宏观环境因素在塑造精准医疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解精准医疗市场竞争态势

精准医疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵精准医疗市场厂商绩效评估

FPNV定位矩阵是评估精准医疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了精准医疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，精准医疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 更多政府资助和更多线上协作论坛
      • 人工智慧在精准医疗的应用不断增加
      • Start-Ups的活跃补充了癌症生物学的进步
    • 抑制因素
      • 缺乏精准医学治疗的覆盖范围
    • 机会
      • 精准医疗中越来越多地采用云端基础的解决方案
      • 製药公司和软体公司建立策略联盟来表征基因
    • 任务
      • FDA 复杂药物治疗核准率
  • 市场区隔分析
    • 技术：巨量资料分析正在推进精准医疗领域
    • 应用：使用精准医学进行个人化癌症和肿瘤护理
    • 最终用户：生技和诊断公司为推动精准医疗领域的研发投资和努力。
    • 部署：融合AI和云端解决方案，提升精准医疗服务开发效率与速度
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章精准医疗市场：依技术分类

  • 巨量资料分析
  • 生物资讯学
  • 伴同性诊断
  • 药物发现
  • 基因序列分析

第七章精准医疗市场：依应用分类

  • 中枢神经系统
  • 免疫学
  • 肿瘤学
  • 呼吸系统

第八章精准医疗市场：依最终用户分类

  • 生物技术和诊断公司
  • 研究所/製药
  • 研究中心和政府机构

第九章精准医疗市场：依发展划分

  • 在云端
  • 本地

第十章美洲精准医疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太精准医疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲精准医疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Tirona 筹集 750 万欧元新资金筹措，以加速精准医疗突破性创新的实施
    • 诺华完成对精准医疗开发商 Chinook 的收购
    • 达特茅斯学院的新中心利用人工智慧改善健康结果
  • 战略分析和建议

公司名单

  • AccessDX Holdings
  • Adaptive Biotechnologies Corporation
  • Biocrates Life Sciences AG
  • bioMerieux SA
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc.
  • Guardant Health, Inc.
  • healthOme
  • Illumina, Inc.
  • Intomics by ZS Associates, Inc.
  • Invitae Corporation.
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Natera Inc.
  • Novartis AG
  • Pfizer Inc.
  • Precision Medicine Group, LLC
  • QIAGEN GmbH
  • Quest Diagnostics Incorporated
  • Strata Oncology, Inc.
  • Syapse, Inc.
  • Tempus Labs, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-030EE48515D0

The Precision Medicine Market was valued at USD 68.12 billion in 2023, expected to reach USD 75.70 billion in 2024, and is projected to grow at a CAGR of 11.22%, to USD 143.43 billion by 2030.

Precision medicine involves tailoring medical treatment to the individual characteristics of each patient, considering factors like genetics, environmental aspects, and lifestyle. This approach is reshaping medical practices by allowing more personalized and effective healthcare solutions. The necessity for precision medicine is underscored by its potential to improve patient outcomes and reduce healthcare costs, catering to the heightened need for personalized treatment plans in managing diseases like cancer, cardiovascular conditions, and genetic disorders. In terms of application, precision medicine spans genomics, digital health technologies, and biomarker analysis, making it pivotal in drug development, early detection of diseases, and therapy selection. The end-use scope is broad, affecting sectors such as biopharmaceuticals, diagnostic companies, and healthcare providers. Influencing growth factors include advancements in genomics, increased R&D investments, and a growing emphasis on targeted therapies. Moreover, governmental support, combined with collaborations between biotech firms and academic institutions, is driving market expansion. Emerging opportunities lie in AI-driven genomic analytics and the integration of big data to enhance predictive outcomes. For businesses aiming to seize these opportunities, investing in data analytics and forging partnerships for innovative solutions will be critical. However, there are challenges like high costs of development, data privacy concerns, and regulatory hurdles that could impede growth. Limited awareness and acceptance among healthcare providers and patients also pose significant barriers. The best areas for innovation include developing cost-effective genomic technologies and advancing precision diagnostics. Exploring new business models that promote patient accessibility and engagement can unlock additional growth. The market is inherently dynamic, with rapid technological advancements necessitating agility and foresight from stakeholders. Businesses should focus on integrating cutting-edge technologies and creating scalable solutions to remain competitive while addressing the nuanced demands of personalized healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 68.12 billion
Estimated Year [2024] USD 75.70 billion
Forecast Year [2030] USD 143.43 billion
CAGR (%) 11.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Medicine Market

The Precision Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funding and rising online collaborative forums
    • Increasing use of artificial intelligence in precision medicine
    • Advancement in cancer biology complemented by the active presence of startups
  • Market Restraints
    • Lack of reimbursement for precision medicine-based treatment
  • Market Opportunities
    • Growing adoption of cloud-based solutions in precision medicine
    • Strategic alliances among pharmaceutical and software companies to characterize the genes
  • Market Challenges
    • Complicated FDA pharmacotherapy approval rate

Porter's Five Forces: A Strategic Tool for Navigating the Precision Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Medicine Market

A detailed market share analysis in the Precision Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Medicine Market

A strategic analysis of the Precision Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AccessDX Holdings, Adaptive Biotechnologies Corporation, Biocrates Life Sciences AG, bioMerieux SA, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Foundation Medicine, Inc., Guardant Health, Inc., healthOme, Illumina, Inc., Intomics by ZS Associates, Inc., Invitae Corporation., Laboratory Corporation of America Holdings, Medtronic PLC, Natera Inc., Novartis AG, Pfizer Inc., Precision Medicine Group, LLC, QIAGEN GmbH, Quest Diagnostics Incorporated, Strata Oncology, Inc., Syapse, Inc., Tempus Labs, Inc., Teva Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Big Data Analytics, Bioinformatics, Companion Diagnostics, Drug Discovery, and Gene Sequencing.
  • Based on Application, market is studied across CNS, Immunology, Oncology, and Respiratory.
  • Based on End-User, market is studied across Biotechnology & Diagnostic Companies, Laboratories & Pharmaceuticals, and Research Centers & Government Institutions.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funding and rising online collaborative forums
      • 5.1.1.2. Increasing use of artificial intelligence in precision medicine
      • 5.1.1.3. Advancement in cancer biology complemented by the active presence of startups
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement for precision medicine-based treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of cloud-based solutions in precision medicine
      • 5.1.3.2. Strategic alliances among pharmaceutical and software companies to characterize the genes
    • 5.1.4. Challenges
      • 5.1.4.1. Complicated FDA pharmacotherapy approval rate
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Big data analytics is advancing the field of precision medicine
    • 5.2.2. Application: Personalized cancer and oncology care using precision medicine
    • 5.2.3. End-user: Efforts by biotechnology and diagnostic companies to invest in R&D and advance the field of precision medicine
    • 5.2.4. Deployment: Integration of AI and cloud solutions to improve efficacy and speed of development of precision medicine services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Big Data Analytics
  • 6.3. Bioinformatics
  • 6.4. Companion Diagnostics
  • 6.5. Drug Discovery
  • 6.6. Gene Sequencing

7. Precision Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. CNS
  • 7.3. Immunology
  • 7.4. Oncology
  • 7.5. Respiratory

8. Precision Medicine Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology & Diagnostic Companies
  • 8.3. Laboratories & Pharmaceuticals
  • 8.4. Research Centers & Government Institutions

9. Precision Medicine Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Precision Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Precision Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Precision Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Thirona Raises EUR 7.5 Million New Financing to Accelerate the Adoption of its Breakthrough Innovations for Precision Medicine
    • 13.3.2. Novartis completes acquisition of precision medicine developer Chinook
    • 13.3.3. New Dartmouth Center Applies AI to Improve Health Outcomes
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AccessDX Holdings
  • 2. Adaptive Biotechnologies Corporation
  • 3. Biocrates Life Sciences AG
  • 4. bioMerieux SA
  • 5. Caris Life Sciences
  • 6. Exact Sciences Corporation
  • 7. F. Hoffmann-La Roche AG
  • 8. Foundation Medicine, Inc.
  • 9. Guardant Health, Inc.
  • 10. healthOme
  • 11. Illumina, Inc.
  • 12. Intomics by ZS Associates, Inc.
  • 13. Invitae Corporation.
  • 14. Laboratory Corporation of America Holdings
  • 15. Medtronic PLC
  • 16. Natera Inc.
  • 17. Novartis AG
  • 18. Pfizer Inc.
  • 19. Precision Medicine Group, LLC
  • 20. QIAGEN GmbH
  • 21. Quest Diagnostics Incorporated
  • 22. Strata Oncology, Inc.
  • 23. Syapse, Inc.
  • 24. Tempus Labs, Inc.
  • 25. Teva Pharmaceutical Industries Ltd.
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PRECISION MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 193. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023